منابع مشابه
Who gets renal bone disease before beginning dialysis?
To identify patients at risk from renal bone disease we compared the demographic characteristics of 243 patients with end stage renal failure grouped according to the presence (97 (40%] or absence of severe renal bone disease as judged by histological criteria. Youth, female sex, tubulointerstitial types of nephropathy, and a long duration of uraemia were all identified as significant independe...
متن کاملRenal bone disease in black dialysis patients: are algorithms developed for white dialysis patients valid?
Sir, Considering the increasing evidence that abnormalities in serum levels of phosphorus, calcium and parathyroid hormone (PTH) contribute to the risk of cardiovascular disease in patients with renal failure, a group of experts has recommended the use of clinical algorithms for the management of renal osteodystrophy w1x. The group opines that these algorithms may be applicable to renal patient...
متن کاملBone scan in Erdheime Chester disease [Persian]
In spite of very high sensitivity, bone scan is quite nonspecific in evaluation of bony lesions. In interpretation of bone scan special attention to patient’s clinical presentation and correlation with other lab and imaging modalities should be paid. In this report a patient with Erdheim Chester disease a rare and unusual form of lipidosis is presented and the pattern of 99mTc-MDP bone sc...
متن کاملAssociation between indoxyl sulfate and bone histomorphometry in pre-dialysis chronic kidney disease patients.
INTRODUCTION Experimental studies have suggested that indoxyl sulfate (IS), a protein-bound uremic toxin, may be involved in the development of renal osteodystrophy. OBJECTIVE evaluate the association between IS levels and biochemical parameters related to mineral metabolism and bone histomorphometry in a cohort of pre-dialysis chronic kidney disease (CKD) patients. METHODS This is a post-h...
متن کاملBone Biomarkers Help Grading Severity of Coronary Calcifications in Non Dialysis Chronic Kidney Disease Patients
BACKGROUND Osteoprotegerin (OPG) and fibroblast growth factor-23 (FGF23) are recognized as strong risk factors of vascular calcifications in non dialysis chronic kidney disease (ND-CKD) patients. The aim of this study was to investigate the relationships between FGF23, OPG, and coronary artery calcifications (CAC) in this population and to attempt identification of the most powerful biomarker o...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Nephrology Dialysis Transplantation
سال: 2014
ISSN: 0931-0509,1460-2385
DOI: 10.1093/ndt/gfu157